Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

Nicholas A. Kennedy, James R. Goodhand, Claire Bewshea, Rachel Nice, Desmond Chee, Simeng Lin, Neil Chanchlani, Jeffrey Butterworth, Rachel Cooney, Nicholas M. Croft, Ailsa L. Hart, Peter M. Irving, Klaartje B. Kok, Christopher A. Lamb, Jimmy K. Limdi, Jonathan MacDonald, Dermot P. B. McGovern, Shameer J. Mehta, Charles D. Murray, Kamal V. PatelRichard C. G. Pollok, Timothy Raine, Richard K. Russell, Christian P. Selinger, Philip J. Smith, Jack Bowden, Timothy J. McDonald, Charlie W. Lees, Shaji Sebastian, Nicholas Powell, Tariq Ahmad (Lead / Corresponding author), , Craig Mowat (Contributing member)

Research output: Contribution to journalArticlepeer-review

141 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology